Article Details

Pfizer's rejig made for growth, but it's also handy for a future split: executives

Retrieved on: 2018-07-31 00:41:15

Tags for this article:

Click the tags to see associated articles and topics

Pfizer's rejig made for growth, but it's also handy for a future split: executives. View article details on hiswai:

Excerpt

<div>“Based on our calculation, other income drove the majority (~$0.06) of the beat,” which largely comprises “unrealized gains on <b>equity securities</b>, higher ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up